Loading chat...
NJ A3359
Bill
Status
Passed
1/13/2026
Primary Sponsor
Sterley Stanley
Click for details
AI Summary
- Nursing homes must have a consultant pharmacist and either a provider pharmacist or, if operating an in-house pharmacy, a director of pharmaceutical services, with these roles filled by New Jersey licensed pharmacists
- Each facility must establish an interdisciplinary pharmacy and therapeutics committee including the administrator, nursing staff representative, and consultant pharmacist, meeting at least quarterly and maintaining records of activities and recommendations
- Consultant pharmacists must be independent from the facility's director of pharmaceutical services and provider pharmacist, and must attest they have no affiliation with either role to prevent conflicts of interest
- Facilities keeping emergency injectable or oral controlled substances must maintain current DEA registration and controlled dangerous substance registration for that location
- The Commissioner of Health, in consultation with the State Board of Pharmacy, will adopt implementing regulations under the Administrative Procedure Act
Legislative Description
Regulates provision of pharmaceutical services in nursing homes.
Withdrawn Because Approved
Last Action
Withdrawn Because Approved P.L.2025, c.294.
1/13/2026
Full Bill Text
No bill text available